Citi Starts Amgen (AMGN) at Neutral
Tweet
Share
E-mail
Get Alerts AMGN Hot Sheet
Price: $432.42 -1.05%
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Rating Summary:
20 Buy, 18 Hold, 5 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 5 | New: 3
Join SI Premium – FREE
Citi initiated coverage on Amgen (NASDAQ: AMGN) with a Neutral rating and a price target of $165.00.
For an analyst ratings summary and ratings history on Amgen click here. For more ratings news on Amgen click here.
Shares of Amgen closed at $147.11 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Amgen's Tezspire meets all endpoints in phase 3 esophagitis trial
- FTC files amicus brief challenging Amgen's Enbrel patent acquisition
- Stifel Starts The Metals Company (TMC) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
